|
A new study from researchers at the University of Toronto and the Sunnybrook Research Institute has shown that a common diabetes medication may have the potential to slow memory loss in patients with Alzheimer’s disease. The research team found that the rate of memory decline was slower in people with Alzheimer’s disease who took a specific class of anti-diabetic drug, known as a dipeptidyl peptidase-4 (DPP4) inhibitor.
|